Ipamorelin + CJC-1295 No-DAC — Combined Timing and Dose Planner
Ipamorelin + CJC-1295 No-DAC reconstitution calculator
How much bacteriostatic water for a 30-day supply?
For a 30-day supply at 5 mg Ipamorelin and 2 mg CJC-1295 No-DAC per week, you need 20 mg Ipamorelin and 8 mg CJC-1295 No-DAC total. That reconstitutes in 4 mL bacteriostatic water across four 5 mg Ipamorelin vials and four 2 mg CJC-1295 No-DAC vials.
Bacteriostatic water (0.9% benzyl alcohol preserved) maintains antimicrobial effect for 28 days after first puncture per USP <797> beyond-use dating guidance for multi-dose vials at controlled room temperature.
For research use only — not clinical guidance.
CJC-1295 No-DAC half-life vs. DAC — what changes
CJC-1295 with DAC has a plasma half-life of approximately 6-8 days. The biotinyl-DAC moiety binds albumin, which circulates for about 19 days in humans. One injection covers roughly a week.
CJC-1295 No-DAC (Mod GRF 1-29) has a half-life of approximately 30 minutes. Dipeptidyl peptidase IV and other circulating proteases degrade the native 1-29 fragment quickly. Daily or twice-daily injection is required.
The No-DAC form means daily dual draws from two vials — one Ipamorelin, one CJC — combined into a single syringe. Your bacteriostatic water volume per vial needs to be generous enough for accurate U-100 insulin syringe measurement but not so dilute that subcutaneous injection volume becomes excessive.
mcg per unit on a U-100 insulin syringe
A U-100 insulin syringe has 100 units per 1 mL. Each unit equals 0.01 mL (10 microliters). U-100 refers to insulin concentration, not a fixed volume — but the volume math is consistent across all U-100 syringes.
Concentration (mcg/mL) = Total peptide (mcg) ÷ Total diluent (mL)
mcg per unit = Concentration ÷ 100
Example — 5 mg Ipamorelin vial:
- 5000 mcg ÷ 2 mL = 2500 mcg/mL
- 2500 ÷ 100 = 25 mcg per unit
A 250 mcg dose = 10 units. A 500 mcg dose = 20 units.
Example — 2 mg CJC-1295 No-DAC vial:
- 2000 mcg ÷ 2 mL = 1000 mcg/mL
- 1000 ÷ 100 = 10 mcg per unit
A 100 mcg dose = 10 units. A 200 mcg dose = 20 units.
Common error: using 1 mL diluent in a 5 mg vial to keep injection volume low. That gives 5000 mcg/mL = 50 mcg per unit. A 250 mcg dose becomes 5 units — drawable but with almost no margin for syringe dead space or air bubbles. A 100 mcg dose becomes 2 units, which is genuinely difficult to draw accurately even with a fine-gauge needle.
Combined syringe preparation — step by step
Ipamorelin and CJC-1295 No-DAC are compatible in a single syringe for immediate injection. Both are lyophilized peptides reconstituted in bacteriostatic water, both stable at the slightly acidic pH that bacteriostatic water provides. No separate pH adjustment needed.
- Reconstitute each peptide in its own vial. For a 30-day supply at the protocol above, use 2 mL per 5 mg Ipamorelin vial and 2 mL per 2 mg CJC-1295 No-DAC vial.
- Draw your CJC-1295 No-DAC dose first. A 100 mcg dose = 10 units.
- Draw your Ipamorelin dose second. A 250 mcg dose = 10 units at 25 mcg/unit.
- Total syringe volume: 20 units = 0.2 mL.
- Inject subcutaneously, rotating sites.
Why draw CJC first: the needle hub holds roughly 1-2 units that never fully mixes. Drawing the smaller-volume peptide first means any residual in the hub is the smaller dose, reducing error if you don't fully clear the needle.
Practical detail most protocols omit: after drawing both peptides, pull back an extra 1-2 units of air into the syringe, invert, and tap to collect the air bubble at the plunger end. This pushes the full volume through the needle without leaving 1-2 units in the hub — 10-25 mcg of peptide you didn't actually inject.
Dose table — 30-day combined protocol
Assumes 5 mg Ipamorelin vial + 2 mL bacteriostatic water (25 mcg/unit) and 2 mg CJC-1295 No-DAC vial + 2 mL (10 mcg/unit). Weekly totals: 5 mg Ipamorelin, 2 mg CJC-1295 No-DAC.
| Dose (Ipamorelin) | Units on U-100 | Dose (CJC No-DAC) | Units on U-100 | Total Syringe Volume | |---|---|---|---|---| | 200 mcg | 8 units | 100 mcg | 10 units | 18 units (0.18 mL) | | 250 mcg | 10 units | 100 mcg | 10 units | 20 units (0.20 mL) | | 300 mcg | 12 units | 150 mcg | 15 units | 27 units (0.27 mL) | | 400 mcg | 16 units | 200 mcg | 20 units | 36 units (0.36 mL) | | 500 mcg | 20 units | 200 mcg | 20 units | 40 units (0.40 mL) |
30-day supply at 250 mcg Ipamorelin / 100 mcg CJC daily: 7.5 mg Ipamorelin and 3 mg CJC-1295 No-DAC. Round up to eight 5 mg Ipamorelin vials and two 2 mg CJC vials — overage covers reconstitution loss and syringe dead space.
Bacteriostatic water volume and peptide degradation over 30 days
The 28-day window from USP <797> applies to the bacteriostatic water's antimicrobial properties — benzyl alcohol evaporates or degrades over time, and each needle puncture introduces potential contamination. Your peptide has a separate stability curve.
Peptides in solution degrade through two primary pathways:
- Hydrolysis — water attacking peptide bonds
- Oxidation — reactive oxygen species modifying side chains
Both are concentration-dependent. A more dilute solution has more water molecules per peptide molecule and more dissolved oxygen per unit volume. A 5 mg vial reconstituted in 1 mL (5000 mcg/mL) generally holds potency longer than the same vial in 5 mL (1000 mcg/mL), assuming identical storage conditions.
The tension: enough volume for accurate U-100 syringe measurements, but not so dilute that the peptide degrades noticeably by day 25. The sweet spot for most research peptides is 2-3 mL per 5 mg vial — enough for 10-unit draws at typical doses, concentrated enough to stay stable for 3-4 weeks refrigerated.
For a 30-day supply, reconstitute fresh every 7-10 days rather than all at once. Four 5 mg vials of Ipamorelin, each reconstituted with 2 mL when needed, keeps peptide concentration high and bacteriostatic water fresh. Same logic for CJC-1295 No-DAC — reconstitute a 2 mg vial weekly rather than a single 8 mg vial for the month.
Sourcing
Bacteriostatic water:
- BAC Water Depot — pre-filled 30 mL multi-dose vials, 0.9% benzyl alcohol, sterile-filtered
- Peptide Waters — 10 mL and 30 mL options, individually packaged
- Medix Solutions — USP-grade, case quantities available
Research peptides:
- Alpha Amino USA — per-lot HPLC/MS COA, US-shipped
- PurePeptides Research — lyophilized in sealed vials, third-party tested
- Research Chem Supply — bulk options, documented purity analysis
For research use only — not clinical guidance.
Frequently asked questions
How much bacteriostatic water is needed for a 30-day supply of Ipamorelin and CJC-1295 No-DAC?
For a 30-day supply at 5 mg Ipamorelin and 2 mg CJC-1295 No-DAC per week, reconstitute in 4 mL bacteriostatic water across four 5 mg Ipamorelin vials and four 2 mg CJC-1295 No-DAC vials, using 2 mL per vial.
What is the half-life of CJC-1295 No-DAC compared to CJC-1295 with DAC?
CJC-1295 No-DAC (Mod GRF 1-29) has a plasma half-life of approximately 30 minutes, degraded by dipeptidyl peptidase IV. In contrast, CJC-1295 with DAC has a half-life of approximately 6-8 days due to albumin binding.
How many mcg per unit are in a 5 mg Ipamorelin vial reconstituted with 2 mL bacteriostatic water?
A 5 mg Ipamorelin vial (5000 mcg) reconstituted with 2 mL bacteriostatic water yields 2500 mcg/mL. On a U-100 insulin syringe, each unit equals 0.01 mL, so each unit contains 25 mcg of Ipamorelin.
Why should CJC-1295 No-DAC be drawn into the syringe before Ipamorelin?
Draw CJC-1295 No-DAC first because the needle hub holds roughly 1-2 units that never fully mix. Drawing the smaller-volume peptide first ensures any residual in the hub is the smaller dose, reducing dosing error if the needle is not fully cleared.